5.88 USD
▼-0.49-7.69%
盘后 8.20 0.00%
2026-09-16
市值
$27.60M
市盈率
—
EPS
-9.94
股息率
—
52 周区间
1.55 – 15.74
成交量
78.85K
Beta
1.34
目标价
20.00
52W 低 1.5552W 高 15.74
价格走势
公司简介
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company’s product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targeting ApoE4 for the treatment of Alzheimer’s disease; and NC605 an antibody that targets Siglec-15, as w...